Jan 30, 2024 | Science, Services
Case Study: Reptor Biological vs Technical Replicates Project Summary Next-generation sequencing of B cell populations (Rep-Seq) has become a powerful tool in immunology and antibody discovery. At Abterra Bio we developed Reptor, an integrated Rep-Seq sequencing and...
Oct 4, 2022 | Products, Science, Services
Advantages of High-Throughput Hybridoma Sequencing with NGS Having a diverse collection of leads at the beginning of your antibody development campaign is critical for downstream success. As we know well, the immune response to immunization often focuses on a small...
Aug 30, 2022 | Products, Science, Services
Why Sequence My Antibody Protein? Over the past decade of sequencing thousands of antibodies, we’ve discovered the top reasons to sequence your antibody protein. Top reasons to sequence my antibody 1. To protect my intellectual property through patents...
Jun 28, 2022 | Science, Services
Case Study: Alicanto Discovers High Affinity Rabbit Antibodies to Detect Neurofibromin Researchers at Infixion Bioscience are on a mission to develop new therapeutics for the “orphan disease” neurofibromatosis type 1, which is diagnosed at a rate 1 in 3000 live...
Mar 17, 2022 | Products, Science, Services
Customer Spotlight: Dr. Matthew Burchill Valens™ Rescues Antibody for Liver Disease Research Dr. Matthew Burchill explains how Abterra Bio’s technology, Valens rescued his antibody and enabled him to continue his research in chronic liver disease. “The...
Feb 22, 2022 | Science, Services
Multi-Species Antibody Repertoire Comparison A decade ago, in vivo antibody discovery relied heavily on wild-type mice. Today, it’s not uncommon to generate antibodies using a petting zoo of animals including chicken, goat, rabbit, llamas, alpacas, and humanized...